-
The Morale Monologue #5 – Avexis Is Expanding Operations To North Carolina
In this episode of the Morale Monologue, I’m giving everyone information regarding Avexis Pharmaceutical, and their announcement regarding their expansion of operations to North Carolina. Illinois-based AveXis, a Novartis company, is developing AVXS-101, a proprietary gene therapy that could prove to be a transformative treatment for babies and children with SMA types 1, 2 and 3.
These treatments will also benefit adults with SMA in the coming future. AveXis is anticipated to invest about $55 million into the new facility and open up about 200 new jobs, giving a boost to the state’s economy while improving its capabilities to manufacture therapies targeting rare neurological and genetic diseases, including spinal muscular atrophy (SMA).
Be sure to subscribe to the SMA News Today YouTube channel so that you don’t miss an episode of this vlog, and you can also connect with me right here on the forums page.
-
0 Replies
Sorry, there were no replies found.
Log in to reply.